Skip to main content

37 Ethicon Physiomesh Cases For The Initial Discovery Pool

37 Ethicon Physiomesh Cases For The Initial Discovery Pool

37 Ethicon Physiomesh Cases For The Initial Discovery Pool

Introduction

The parties involved in the Ethicon hernia mesh litigation filed a notice on November 5 in the U.S. District Court for the Northern District of Georgia, submitting an updated list of 37 cases selected for inclusion for the initial discovery pool. Following case-specific discovery, the parties are required to finalize 10 cases in all by February 14, 2019, ahead of the first bellwether trial which has been scheduled for December 2, 2019.

The defendants named in this litigation are J&J and its subsidiary Ethicon. Plaintiffs injured after receiving the surgical mesh implants allege the defendant's Physiomesh Flexible Composite Mesh is defectively designed and manufactured with patients experiencing higher chances of painful and debilitating complications including infection, adhesions, chronic pain, and hernia recurrence; they further hold the defendants responsible for inadequate pre-market testing and failure to warn the medical community and patients of the potential risks.

In June 2017, MDL No. 2782: In Re: Ethicon Physiomesh Flexible composite Hernia Mesh Products Liability Litigation was established by JPML for coordinated discovery and pretrial proceedings. This burgeoning MDL is assigned to U.S. District Judge Richard Story and currently has more than 1,450 pending lawsuits.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

NC to Get $150M to Boost Opioid Treatment, Recovery

Categories: Opioids

North Carolina will receive an additional $150 million from Purdue Pharma and the Sackler family as part of a national $7.4 billion settlement related to the opioid

SRI Gets FDA OK for High-Dose Naloxone Trial

Categories: Opioids

SRI has received authorization from the U.S. Food and Drug Administration (FDA) to begin Phase 1 clinical trials of a new, high-dose injectable naloxone formulation.

The approval was granted under an Investigational New Drug (IND)…

Spokane County to Get $5M in New Opioid Settlement

Categories: Opioids

Jurisdictions within Spokane County are set to receive nearly $4.7 million as part of a sweeping $7.4 billion nationwide settlement with Purdue Pharma and its owners, the Sackler family.

The agreement addresses the company’s role in fueling…

✍️ FREE—3000 Pages Medical Record Review Trial!                
No Contract. No Risk—Fully Customized, Free!

Only 10 Firms Accepted—Offer Ends June 30!